DRI Healthcare

Julien Bruneau is a Partner at Athene Capital with more than 15 years of experience in private equity. He previously held roles at the Regional Growth Fund, Merrill Lynch Global Private Equity, CIBC World Markets plc, and PAI partners, working on pan-European transactions across business services, building materials, capital goods, consumer, healthcare, and TMT. He holds an MSc in Valuation and Finance from Lyon II University and studied an MSc in Corporate Finance at EM Lyon Business School.

Alyssa Klapper is Associate General Counsel at DRI Healthcare. She is an intellectual property attorney focused on life sciences litigation and transactions.

Chair of the board for Vancouver Airport Authority and an experienced corporate director serving on multiple TSX company boards, including audit committee chair roles at Saputo and The North West Company.

Public sector leader with more than 30 years in senior roles across the Alberta and BC provincial governments and the Government of Canada; most recently President and CEO of Alberta Health Services.

Courtney Grady is a Senior Analyst in Research & Investments at DRI Healthcare, with experience in due diligence, commercialization, and product development. Her earlier career includes roles in life science consulting and the startup sector. She holds a PhD in Biomedical Sciences focused on immunology, infectious disease, and genetics, and has a background in statistics, data management, and project management.

Seasoned corporate director with roughly 20 years of board experience across multiple sectors and senior government roles. Was a Senior Adviser at Lazard Canada from 2016 to 2023 and previously President of Coastal Contacts Inc.

Leader with over 40 years in strategic planning, operations and governance in real estate and retail; President and CEO of Wesbild Holdings since 2008 and former President of Future Shop.

Nina Nguyen is a hematologist at Memorial Healthcare System. Her clinical focus is plasma cell dyscrasias, including multiple myeloma, its precursor conditions smoldering myeloma and MGUS, and amyloid.

Healthcare executive currently CEO of Cydar Medical, an AI and cloud-based medical device company; joined Cydar as a non-executive director in 2019 before becoming CEO in 2020.

Tenured Professor of Law and Chair in Corporate Governance at Osgoode Hall Law School and a corporate lawyer/Affiliated Scholar at Davies Ward Phillips & Vineberg, with expertise in governance.

Business executive with senior leadership experience in finance, transportation, infrastructure and health; currently President and CEO of Vancouver Airport Authority.

A venture capitalist and entrepreneur with 35+ years of experience, Estes was previously an institutional equity broker at A.G. Edwards & Sons and later President and owner of Estes Financial. He entered digital assets in 2012, has authored four books on digital assets, and has raised and managed multiple private venture funds.

Associate Director of the NYU Entrepreneurial Institute, managing the Leslie eLab, Institute finances, and events and operations including the NYU Entrepreneurs Festival. A returned Peace Corps volunteer with an MPA from NYU Wagner.

Gordon Winston is Founder, Chairman, and CEO of QGEMS, Inc. and QSecGrid, Inc., companies developing digital energy infrastructure for distributed energy resources and critical infrastructure modernization. He previously spent 14 years in Wall Street finance and later led the evolution of Drug Royalty Corporation into DRI Capital, an IP-based investment manager with $5 billion in assets under management. Winston serves in the World Presidents' Organization and Young Presidents' Organization, and is co-founder of the Peace Innovation Initiative and Cooperative for Humanity.